Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital ...

32,415 people played the daily Crossword recently. Can you solve it faster than others?32,415 people played the daily Crossword recently. Can you solve it faster than others?

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

It's been a mediocre week for Omnicell, Inc. (NASDAQ:OMCL) shareholders, with the stock dropping 19% to US$25.39 in the week since its latest quarterly results. The results don't look great, ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

Omnicell, Inc. OMCL reported first-quarter 2025 adjusted earnings per share (EPS) of 26 cents compared with 3 cents in the year-ago period. The metric beat the Zacks Consensus Estimate by 62.5% ...

Omnicell Inc. (OMCL) reported its first-quarter 2025 earnings, exceeding Wall Street’s expectations with an earnings per share (EPS) of $0.26, surpassing the forecasted $0.21. Despite this positive ...

CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...

Omnicell shares fell after the company lowered its guidance due to expected costs and uncertainty from tariffs. The stock slid 15% to $26.01 on Tuesday morning, at one point touching a 52-week low ...